Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q3 2019 · 10-Q
Revenue$534.00K$534.00K+92.8% vs Q3 2018 Net Income-$3.89M-$3.89MN/M vs Q3 2018 EPS Diluted-$0.02-$0.02N/M vs Q3 2018 Gross Profit$268,000+72.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,330,000N/M Margins · derivedGross margin50.2%−5.8 pt vs Q3 2018
Operating margin-352.8%+248.3 pt vs Q3 2018
Net margin-727.7%+130.8 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end